TABLE 4.
Antifungal drug and peak serum-level concn (%) usedb | Organism used | BacT/Alert FAP bottles |
Bactec PAF bottles |
Bactec MICF bottles |
||||
---|---|---|---|---|---|---|---|---|
Recovery (no. of bottles detected as positive/no. of bottles tested) | Mean time (h) to detection | Recovery (no. of bottles detected as positive/no. of bottles tested) | Mean time (h) to detection | Recovery (no. of bottles detected as positive/no. of bottles tested) | Mean time (h) to detection | |||
Amphotericin B | 100 | C. albicans | 2/2 | 23.5 | 2/2 | 33.5 | 0/2 | – |
50 | 2/2 | 22.7 | 2/2 | 27.5 | 2/2 | 51.9 | ||
25 | 2/2 | 22.5 | 2/2 | 27.1 | 2/2 | 50.2 | ||
No drug | 2/2 | 22.2 | 2/2 | 24.6 | 2/2 | 18.7 | ||
100 | C. glabrata | 2/2 | 18.7 | 2/2 | 49.4 | 0/2 | – | |
50 | 2/2 | 18.7 | 2/2 | 43.2 | 0/2 | – | ||
25 | 2/2 | 18.5 | 2/2 | 42.1 | 0/2 | – | ||
No drug | 2/2 | 17.4 | 2/2 | 32.1 | 2/2 | 16.2 | ||
100 | C. krusei | 2/2 | 25.7 | 2/2 | 35.4 | 0/2 | – | |
50 | 2/2 | 23.7 | 2/2 | 30.6 | 2/2 | 37.2 | ||
25 | 2/2 | 23.6 | 2/2 | 29.1 | 2/2 | 33.2 | ||
No drug | 2/2 | 22.1 | 2/2 | 26.0 | 2/2 | 21.7 | ||
100 | C. parapsilosis | 2/2 | 39.8 | 2/2 | 46.9 | 0/2 | – | |
50 | 2/2 | 38.6 | 2/2 | 41.6 | 2/2 | 52.1 | ||
25 | 2/2 | 36.5 | 2/2 | 40.3 | 2/2 | 48.2 | ||
No drug | 2/2 | 36.4 | 2/2 | 30.9 | 2/2 | 31.7 | ||
100 | C. tropicalis | 2/2 | 27.0 | 2/2 | 31.2 | 0/2 | – | |
50 | 2/2 | 24.3 | 2/2 | 30.6 | 2/2 | 50.7 | ||
25 | 2/2 | 22.1 | 2/2 | 28.1 | 2/2 | 48.8 | ||
No drug | 2/2 | 21.0 | 2/2 | 20.4 | 2/2 | 19.4 |
Candida species were allowed to grow in the presence of amphotericin B antifungal agent in resin containing (BacT/Alert FAP and Bactec PAF) or non-containing (Bactec MICF) blood culture bottles, following bottles’ incubation in the BacT/Alert VIRTUO or the Bactec FX blood culture automated system, respectively. In the case of recovery, the times to detection were recorded for each of the Candida species used in the study. The symbol – indicates no recovery.
See text and Table S1 for details.